Heart Arteries and Sickle Cell Disease / Coeur Artères DREpanocytose

NCT03114137 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4500

Last updated 2018-05-25

No results posted yet for this study

Summary

The CADRE study is a multinational observational cohort of patients with sickle-cell disease (SCD) in five west and central sub-Saharan African countries. The aim of this project is to describe the incidence and assess the predictive factors of SCD-related micro- and macro-vascular complications in sub-Saharan Africa.

Conditions

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV
  • University of Paris 5 - Rene Descartes

    collaborator OTHER
  • laboratory of excellence GR-Ex

    collaborator UNKNOWN
  • Cardiologie et Développement

    lead OTHER

Principal Investigators

  • Xavier Jouven, MD PhD · Cardiologie et Developpement

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2020-12-31
Completion
2022-12-31

Countries

  • Cameroon
  • Côte d’Ivoire
  • Democratic Republic of the Congo
  • Gabon
  • Mali
  • Senegal

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03114137 on ClinicalTrials.gov